Pradaxa Bleeding Lawsuits May Be Headed to Special Federal Court

• 

Alerting patients who’ve suffered internal bleeding after taking the drug Pradaxa that a special federal court may be established to handle Pradaxa side effects lawsuits.

Dallas, TX (PRWEB) June 12, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who’ve suffered internal bleeding after taking the drug Pradaxa that a special federal court may be established to handle Pradaxa side effects lawsuits.

The news comes as a report published this month shows more Pradaxa deaths were reported to the FDA last year than with any other drug.

Anyone who has suffered a bleeding episode after taking Pradaxa or lost a loved one is urged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa, which was released in October, 2010, is an anticoagulant prescribed to those with atrial fibrillation in order to prevent strokes. The Wall Street Journal reported on April 24, 2012, that the drug already reached the $1 billion blockbuster sales mark for the 12-month period ending in February.

Unfortunately, the FDA warned on December 7, 2011 that it was investigating the safety of Pradaxa after receiving higher than expected reports of injury or death. Last month on May 25th, the European Medicines Agency also issued a statement saying that warnings should be added to give doctors and patients a clearer picture of the risks.

Now, the Philadelphia Inquirer reported on June 6th that Pradaxa led all other medications in 2011 for number of death reports. The data was compiled by the Institute for Safe Medication Practices' QuarterWatch program, which tracks reports to the FDA’s MedWatch.

According to the article, Pradaxa also ranked highest for total adverse reports (3,781), deaths (542), hemorrhage (2,367), acute renal failure (291), and stroke (644).

Due to the number of lawsuits expected over Pradaxa side effects, a motion was recently filed to consolidate the cases into one central federal court. The Motion was filed on May 30, 2012 in Case MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. In the motion, lawyers state they expect as many as 500 cases will be filed.

Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. However, due to the specialized nature of these federal MDL cases, only certain lawyers can help. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, Pradaxa side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

PDF Print